Rodent Intravenous Infusion Capabilities Expanded to Nevada Facility
March 8, 2010 – As we continue to expand our capabilities to meet customer needs, we are pleased to announce that beginning in Q3 2010, our Nevada facility will offer continuous intravenous infusion services in rodents. Specifically, these services include:
- GLP studies ranging from acute through chronic (or up to four weeks in duration)
- Evaluation of standard toxicity parameters (clinical observations, body weights, ophthalmic exams, serum chemistry, hematology, coagulation, urinalysis and TK)
- Intermittent and continuous infusion dosing regimens
- Various infusion rates
Our global preclinical laboratories have more than 25 years of experience conducting both intermittent and continuous infusion studies in rodent and nonrodent species. The studies we offer worldwide include continuous infusion using indwelling catheters and single infusions using indwelling or peripheral catheters. In addition, our experience with a wide range of compounds enables us to help you analyze and develop pharmaceutical and biopharmaceutical compounds with unique characteristics.
By extending this global expertise in rodent infusion services to our Nevada facility, we can continue to help you meet the ever-increasing challenges of your drug research and development program. For more information about these services, contact us at 1.877.CRIVER.1 (1.877.274.8371) or askcharlesriver@crl.com.
Related Information: